Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.

Björkholm C, Jardemark K, Marcus MM, Malmerfelt A, Nyberg S, Schilström B, Svensson TH.

Eur Neuropsychopharmacol. 2013 Jul;23(7):709-20. doi: 10.1016/j.euroneuro.2012.05.012. Epub 2012 Jun 23.

PMID:
22732518
2.

Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.

Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH.

Neuropsychopharmacology. 2010 Aug;35(9):1952-61. doi: 10.1038/npp.2010.69. Epub 2010 May 12.

3.
4.
5.

Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.

Eltayb A, Wadenberg ML, Svensson TH.

Biol Psychiatry. 2005 Aug 15;58(4):337-43.

PMID:
16102547
6.

Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.

Masana M, Bortolozzi A, Artigas F.

Int J Neuropsychopharmacol. 2011 Feb;14(1):53-68. doi: 10.1017/S1461145710000908. Epub 2010 Aug 12.

PMID:
20701825
7.

Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.

Marcus MM, Jardemark K, Malmerfelt A, Gertow J, Konradsson-Geuken A, Svensson TH.

Synapse. 2012 Apr;66(4):277-90. doi: 10.1002/syn.21510. Epub 2011 Dec 13.

PMID:
22121030
9.
10.

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.

Nyberg S, Jucaite A, Takano A, Kågedal M, Cselényi Z, Halldin C, Farde L.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2235-44. doi: 10.1017/S1461145713000680. Epub 2013 Jul 1.

PMID:
23809226
11.

Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.

Cross AJ, Widzowski D, Maciag C, Zacco A, Hudzik T, Liu J, Nyberg S, Wood MW.

Br J Pharmacol. 2016 Jan;173(1):155-66. doi: 10.1111/bph.13346. Epub 2015 Dec 1.

12.

Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.

Linnér L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH.

J Pharmacol Exp Ther. 2001 May;297(2):540-6.

13.
14.

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu068. doi: 10.1093/ijnp/pyu068.

15.

Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.

Wadenberg ML, Wiker C, Svensson TH.

Int J Neuropsychopharmacol. 2007 Apr;10(2):191-202. Epub 2006 May 17.

PMID:
16707032
16.

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F.

Psychopharmacology (Berl). 2000 Jul;150(4):422-9.

PMID:
10958084
17.

The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.

Mizoguchi N, Saigusa T, Aono Y, Sekino R, Takada K, Oi Y, Ueda K, Koshikawa N, Cools AR.

Eur J Pharmacol. 2008 Dec 28;601(1-3):94-8. doi: 10.1016/j.ejphar.2008.10.045. Epub 2008 Nov 5.

PMID:
18996113
18.

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.

Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL.

Neuropsychopharmacology. 2008 Sep;33(10):2303-12. Epub 2007 Dec 5.

19.

Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine.

Jardemark KE, Konradsson A, Schilström B, Marcus MM, Svensson TH.

Synapse. 2009 Oct;63(10):913-20. doi: 10.1002/syn.20674.

PMID:
19582782

Supplemental Content

Support Center